Presents Three Abstracts for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO NANTES, France - ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

2025 Q3 Financial Results (as of September 30, 2025) ...

Eagles star Jake Waterman says it’s “no coincidence” he’s playing career-best footy after his life-changing illness. Watch every match of the 2025 AAMI Community Series Live & ad-break free during ...

Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data ...

EQS-News: ABIVAX / Key word (s): Miscellaneous Abivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

Discover how air pollution impacts autoimmune diseases like rheumatoid arthritis and lupus, based on groundbreaking genetic ...

Galapagos (0JXZ – Research Report) received a Sell rating and a €22.00 price target from Barclays analyst Emily Field today. The company’s ...